137334-84-0

Basic information

• Product Name: 1,4-bis(4-carboxy-4-methylpentyl)benzene
• Synonyms: 1,4-bis(4-carboxy-4-methylpentyl)benzene
• CAS NO: 137334-84-0
• Molecular Weight: 334.456
• Mol File: 137334-84-0.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 1,4-bis(4-carboxy-4-methylpentyl)benzene(CAS DataBase Reference)
• NIST Chemistry Reference: 1,4-bis(4-carboxy-4-methylpentyl)benzene(137334-84-0)
• EPA Substance Registry System: 1,4-bis(4-carboxy-4-methylpentyl)benzene(137334-84-0)

Safety Data

• Hazardous Substances Data: 137334-84-0(Hazardous Substances Data)

Upstream product

• 19417-59-5 1,4-bis-(3-bromopropyl)-benzene 
• 4251-21-2 3,3'-(1,4-phenylene)dipropanoic acid 
• 623-27-8 terephthalaldehyde, 
• 35288-49-4 p-phenylenediacrylic diacid dichloride 
• 16323-43-6 1,4-phenylenediacrylic acid 
• 5312-03-8 dimethyl 3,3'-(1,4-phenylene)dipropanoate 
• 7549-44-2 dimethyl-1,4-phenylenediacrylate 
• 19417-58-4 [1,4-phenylene]-bis(3-hydroxypropane) 
• 79-31-2 isobutyric Acid 

Downstream Products

• 137334-86-2 1,4-bis(6-diazo-4,4-dimethyl-5-oxohexyl)benzene 
• 137334-87-3 1,4-bis<4,4-dimethyl-5-(ethoxycarbonyl)pentyl>benzene 
• 137334-85-1 1,4-bis<4-(chloroformyl)-4-methylpentyl>benzene 

Relevant articles and documents

FUNCTIONALIZED LONG-CHAIN HYDROCARBON MONO- AND DI-CARBOXYLIC ACIDS AND THEIR USE FOR THE PREVENTION OR TREATMENT OF DISEASE

This invention provides compounds of Formulae (IA), (IB), (IC), (ID), (IE), (IF), (IG), (IH), (IJ), (IK), (IL), (II), (III), (IIIA), and (IIIB); pharmaceutically acceptable salts and solvates thereof; and compositions thereof. This invention further provides methods for treating a disease, including but not limited to, liver disease or an abnormal liver condition; cancer (such as hepatocellular carcinoma or cholangiocarcinoma); a malignant or benign tumor of the lung, liver, gall bladder, bile duct or digestive tract; an intra- or extra-hepatic bile duct disease; a disorder of lipoprotein; a lipid-and-metabolic disorder; cirrhosis; fibrosis; a disorder of glucose metabolism; a cardiovascular or related vascular disorder; a disease resulting from steatosis, fibrosis, or cirrhosis; a disease associated with increased inflammation (such as hepatic inflammation or pulmonary inflammation); hepatocyte ballooning; a peroxisome proliferator activated receptor-associated disorder; an ATP citrate lyase disorder; an acetyl-coenzyme A carboxylase disorder; obesity; pancreatitis; or renal disease.